The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| PHG | -7.39% | -32.22% | -7.48% | +1,513% |
| S&P | +14.5% | +93.32% | +14.09% | +3,896% |
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care businesses segment consists Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care and Connected Care Informatics. The Personal Health businesses segment consists of Oral Healthcare, Personal Care,Mother and Child Care. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $4.92B | 2.4% |
| Gross Profit | $2.28B | 0.0% |
| Gross Margin | 46.36% | 0.0% |
| Market Cap | $6.33B | -3.3% |
| Market Cap / Employee | $0.09M | 0.0% |
| Employees | 67.3K | 0.0% |
| Net Income | $274.51M | -43.6% |
| EBITDA | $773.61M | 0.0% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $2.14B | 0.0% |
| Accounts Receivable | $4.00B | -5.8% |
| Inventory | 3.8K | 0.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $8.43B | 0.0% |
| Short Term Debt | $1.46B | 0.0% |
| Q4 2024 | YOY Change | |
|---|---|---|
| Return On Assets | -2.88% | 0.0% |
| Return On Invested Capital | -1.29% | -2.3% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $317.91M | 0.0% |
| Operating Free Cash Flow | $388.32M | 0.0% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 0.67 | 0.52 | 0.52 | 0.49 | -1.23% |
| Price to Tangible Book Value | -5.50 | -4.26 | -4.57 | -4.47 | -22.12% |
| Enterprise Value to EBITDA | 59.99 | 39.72 | - | ||
| Return on Equity | -7.1% | - | |||
| Total Debt | $8.49B | $7.91B | $8.18B | $9.89B | - |
PHG earnings call for the period ending September 30, 2021.
PHG earnings call for the period ending June 30, 2021.
PHG earnings call for the period ending March 31, 2021.
PHG earnings call for the period ending December 31, 2020.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
